Skip to main content

Table 1 Maternal and neonatal complications

From: Maternal and neonatal complications after IVF/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study

 

POSEIDON Group 1

(n = 2554)

POSEIDON Group 2

(n = 971)

POSEIDON Group 3

(n = 141)

POSEIDON Group 4

(n = 142)

Control

(n = 3820)

P value

vanishing twin syndrome

106(4.2)

32(3.3)a

8(5.7)

1(0.7)abd

187(4.9)

0.031

GDM

160(6.3)

78(8.0)a

9(6.4)

20(14.1)abcd

199(5.2)

 < 0.001

HDP

58(2.3)

39(4.0)ab

7(5.0)

6(4.2)

92(2.4)

0.010

LBW

78(3.3)a

32(3.9)

6(4.7)

2(1.8)

151(4.3)

0.249

PTB

94(3.7)

37(3.8)

6(4.3)

6(4.2)

146(3.8)

0.993

Pregnancy loss

 Total pregnancy loss

159(6.2)a

126(13.0)ab

9(6.4)c

28(19.7)abcd

289(7.6)

 < 0.001

 1st trimester pregnancy loss

100(3.9)a

108(11.1)ab

6(4.3)c

26(18.3)abcd

211(5.5)

 < 0.001

 2nd trimester pregnancy loss

59(2.3)

18(1.9)

3(2.1)

2(1.4)

78(2.0)

0.910

Induction due to malformation

15(0.6)

16(1.6)ab

1(0.7)

4(2.8)ab

28(0.7)

0.005

Placenta previa

29(1.1)

14(1.4)

3(2.1)

3(2.1)

46(1.2)

0.473

Macrosomia

227(9.6)

97(11.7)

16(12.4)

14(12.6)

353(10.1)

0.348

  1. Data are mean ± SD, median (interquartile), or n(%)
  2. ap < 0.05, vs. Control
  3. bp < 0.05, vs. POSEIDON group 1
  4. cp < 0.05, vs. POSEIDON group 2
  5. dp < 0.05, vs. POSEIDON group 3